Cost-Effectiveness Of Dabigatran Versus Factor Xa Inhibitors For Stroke Prevention In Patients With Non-Valvular Atrial Fibrillation Under The Private And Public Health Care System In Brazil
May 1, 2014, 00:00
10.1016/j.jval.2014.03.660
https://www.valueinhealthjournal.com/article/S1098-3015(14)00711-6/fulltext
Title :
Cost-Effectiveness Of Dabigatran Versus Factor Xa Inhibitors For Stroke Prevention In Patients With Non-Valvular Atrial Fibrillation Under The Private And Public Health Care System In Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00711-6&doi=10.1016/j.jval.2014.03.660
First page :
A113
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
92